U.S. approves COVID-19 pill that decreases risk of hospitalization by 90%

with No Comments
This image provided by Pfizer in October 2021 shows the company’s COVID-19 Paxlovid pills. U.S. health regulators authorized the pill.

 

(The Associated Press/ CBC News) — U.S. health regulators on Wednesday authorized the first pill against COVID-19, a Pfizer drug that Americans will be able to take at home to head off the worst effects of the virus.

The long-awaited milestone comes as U.S. cases, hospitalizations and deaths are all rising and health officials warn of a tsunami of new infections from the Omicron variant that could overwhelm hospitals.

The drug, Paxlovid, is a faster, cheaper way to treat early COVID-19 infections, though initial supplies will be extremely limited. All of the previously authorized drugs against the disease require an IV or an injection. (…)

read full story